UNIVERSITY OF ROCHESTER
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.rochester.edu
Clinical Trials
685
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (562 trials with phase data)• Click on a phase to view related trials
Plant-Based Nutrition for Breast or Endometrial Cancer
- Conditions
- Breast Cancer MetastaticEndometrial Cancer Stage IV
- First Posted Date
- 2025-09-24
- Last Posted Date
- 2025-09-24
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 60
- Registration Number
- NCT07189702
A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses
- Conditions
- Breast Abscess
- Interventions
- Procedure: Standard of care breast abscess drainageDrug: Lipid EmulsionDevice: Insertion of optical fiberDevice: Laser illuminationProcedure: Photodynamic therapy
- First Posted Date
- 2025-09-17
- Last Posted Date
- 2025-09-23
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 50
- Registration Number
- NCT07179003
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
SAVE: School Ambassadors for Vaccine Education
- Conditions
- Immunization; Infection
- First Posted Date
- 2025-09-09
- Last Posted Date
- 2025-09-09
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 6000
- Registration Number
- NCT07164144
Assessing Post-operative Outcomes After Children's Sistrunk Procedure With or Without a Drain
- Conditions
- Thyroglossal Duct Cysts
- First Posted Date
- 2025-08-29
- Last Posted Date
- 2025-09-08
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 178
- Registration Number
- NCT07148895
- Locations
- 🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸Connecticut Children's, Hartford, Connecticut, United States
Mechanisms of Visual Restoration After Occipital Stroke
- Conditions
- Cortical BlindnessStroke IschemicVision Loss PartialVisual Fields HemianopsiaHemianopiaHemianopia HomonymousOccipital Lobe Infarct
- First Posted Date
- 2025-08-21
- Last Posted Date
- 2025-08-21
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 100
- Registration Number
- NCT07134777
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 137
- Next
News
Genflow Biosciences Advances SIRT6 Patent Applications in Europe and Japan for Age-Related Disease Therapies
Genflow Biosciences has successfully progressed its SIRT6 variant patent application through the European Patent Office's Supplementary Search Report without additional questions, strengthening its intellectual property position.
PhotoPharmics Reaches 50% Enrollment Milestone in Phase 3 Trial Testing Light Therapy for Parkinson's Disease
PhotoPharmics has enrolled 150 participants in its Light for PD Phase 3 clinical trial, evaluating specialized phototherapy for both motor and non-motor symptoms of Parkinson's disease.
Financial Toxicity Remains Major Barrier in Cancer Care Despite Improved Patient Experience
Recent data shows significant gender disparity in cancer care, with 31% of women and 21% of men reporting their initial health concerns were not taken seriously by healthcare providers.